Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 79

Similar articles for PubMed (Select 19171702)

1.

Progress in defining and treating high-risk neuroblastoma: lessons from the bench and bedside.

Volchenboum SL, Cohn SL.

J Clin Oncol. 2009 Mar 1;27(7):1003-4. doi: 10.1200/JCO.2008.20.2739. Epub 2009 Jan 26. No abstract available.

2.

Exceptional Responders Inspire Change: Lessons for Drug Development From the Bedside to the Bench and Back.

Chau NG, Lorch JH.

Oncologist. 2015 Jul;20(7):699-701. doi: 10.1634/theoncologist.2014-0476. Epub 2015 Jun 3. No abstract available.

PMID:
26040619
3.

Rational therapy from bench to bedside for a rare epilepsy.

Patino GA, Parent J.

Epilepsy Curr. 2014 Sep;14(5):286-8. doi: 10.5698/1535-7597-14.5.286. No abstract available.

4.

From bench to bedside: unique challenges of treating epilepsy in the aging brain.

Shapiro LA.

Aging Dis. 2011 Aug;2(4):275-7. Epub 2011 Aug 30. No abstract available.

5.

Neuroblastoma.

Esiashvili N, Anderson C, Katzenstein HM.

Curr Probl Cancer. 2009 Nov-Dec;33(6):333-60. doi: 10.1016/j.currproblcancer.2009.12.001. Review. No abstract available.

PMID:
20172369
6.

Gene expression profiling: decoding breast cancer.

de Snoo F, Bender R, Glas A, Rutgers E.

Surg Oncol. 2009 Dec;18(4):366-78. doi: 10.1016/j.suronc.2009.07.005. Review.

PMID:
19879448
7.

Neuroblastoma: biology and staging.

Mueller S, Matthay KK.

Curr Oncol Rep. 2009 Nov;11(6):431-8. Review.

PMID:
19840520
8.

Targeted radioiodine therapy of neuroblastoma tumors following systemic nonviral delivery of the sodium iodide symporter gene.

Klutz K, Russ V, Willhauck MJ, Wunderlich N, Zach C, Gildehaus FJ, Göke B, Wagner E, Ogris M, Spitzweg C.

Clin Cancer Res. 2009 Oct 1;15(19):6079-86. doi: 10.1158/1078-0432.CCR-09-0851. Epub 2009 Sep 29.

9.

The role of 131I-MIBG in high-risk neuroblastoma treatment.

Lessig MK.

J Pediatr Oncol Nurs. 2009 Jul-Aug;26(4):208-16. doi: 10.1177/1043454209340316. Review.

PMID:
19726792
10.

Microtubule-associated protein-2 is a sensitive marker of primary and metastatic neuroblastoma.

Krishnan C, Higgins JP, West RB, Natkunam Y, Heerema-McKenney A, Arber DA.

Am J Surg Pathol. 2009 Nov;33(11):1695-704. doi: 10.1097/PAS.0b013e3181b0ebdc.

PMID:
19701075
11.

Proteomic approaches in neuroblastoma: a complementary clinical platform for the future.

Kumar HR, Zhong X, Rescorla FJ, Hickey RJ, Malkas LH, Sandoval JA.

Expert Rev Proteomics. 2009 Aug;6(4):387-94. doi: 10.1586/epr.09.58. Review.

PMID:
19681674
12.

mRNA expression profile of multidrug resistance genes in childhood acute lymphoblastic leukemia. Low expression levels associated with a higher risk of toxic death.

Cortez MA, Scrideli CA, Yunes JA, Valera ET, Toledo SR, Pavoni-Ferreira PC, Lee ML, Petrilli AS, Brandalise SR, Tone LG.

Pediatr Blood Cancer. 2009 Dec;53(6):996-1004. doi: 10.1002/pbc.22220.

PMID:
19672972
13.

High-dose iodine-131-metaiodobenzylguanidine with haploidentical stem cell transplantation and posttransplant immunotherapy in children with relapsed/refractory neuroblastoma.

Toporski J, Garkavij M, Tennvall J, Ora I, Gleisner KS, Dykes JH, Lenhoff S, Juliusson G, Scheding S, Turkiewicz D, Békássy AN.

Biol Blood Marrow Transplant. 2009 Sep;15(9):1077-85. doi: 10.1016/j.bbmt.2009.05.007. Epub 2009 Jul 8.

14.

Ezrin overexpression in gastrointestinal stromal tumors: an independent adverse prognosticator associated with the non-gastric location.

Wei YC, Li CF, Yu SC, Chou FF, Fang FM, Eng HL, Uen YH, Tian YF, Wu JM, Li SH, Huang WW, Li WM, Huang HY.

Mod Pathol. 2009 Oct;22(10):1351-60. doi: 10.1038/modpathol.2009.107. Epub 2009 Jul 31.

15.

Gene expression profiling in cancers of unknown primary.

Varadhachary GR, Raber MN.

J Clin Oncol. 2009 Sep 1;27(25):e85-6; author reply e87-8. doi: 10.1200/JCO.2009.23.7644. Epub 2009 Jul 27. No abstract available.

16.

Neuroblastoma: treatment outcome after incomplete resection of primary tumors.

Moon SB, Park KW, Jung SE, Youn WJ.

Pediatr Surg Int. 2009 Sep;25(9):789-93. doi: 10.1007/s00383-009-2417-8. Epub 2009 Jul 21.

PMID:
19629500
17.

Gene expression profile analysis in laryngeal cancer by high-density oligonucleotide microarrays.

Markowski J, Oczko-Wojciechowska M, Gierek T, Jarzab M, Paluch J, Kowalska M, Wygoda Z, Pfeifer A, Tyszkiewicz T, Jarzab B, Niedzielska I, Borgiel-Marek H.

J Physiol Pharmacol. 2009 May;60 Suppl 1:57-63.

18.

Complementary value of the Ki-67 proliferation index to the oncotype DX recurrence score.

Gwin K, Pinto M, Tavassoli FA.

Int J Surg Pathol. 2009 Aug;17(4):303-10. doi: 10.1177/1066896909340274. Epub 2009 Jul 3.

PMID:
19578051
19.

Tumor biomarkers in melanoma.

Ugurel S, Utikal J, Becker JC.

Cancer Control. 2009 Jul;16(3):219-24. Review.

20.

Cervical lymph node metastases of squamous cell carcinoma from an unknown primary site: a favourable prognosis subset of patients with CUP.

Pavlidis N, Pentheroudakis G, Plataniotis G.

Clin Transl Oncol. 2009 Jun;11(6):340-8. Review.

PMID:
19531448
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk